DEEPIKA SOOD: Open Payments
NPI 1518170364 · WEST HEMPSTEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124 in 5 payments from 4 companies in 2025. Trend: 2023 $134 · 2024 $191 · 2025 $124
Food & beverage: $124
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: INGREZZA, Auvelity, UZEDY, REXULTI, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
